Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

726 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biweekly irinotecan or raltitrexed plus 6S-leucovorin and bolus 5-fluorouracil in advanced colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase II-III randomized trial.
Comella P, De Vita F, Mancarella S, De Lucia L, Biglietto M, Casaretti R, Farris A, Ianniello GP, Lorusso V, Avallone A, Cartenì G, Leo SS, Catalano G, De Lena M, Comella G. Comella P, et al. Among authors: catalano g. Ann Oncol. 2000 Oct;11(10):1323-33. doi: 10.1023/a:1008375705484. Ann Oncol. 2000. PMID: 11106123 Free article. Clinical Trial.
Dose-finding study of 5'-deoxy-5-fluorouridine in combination with fixed doses of cisplatin and L-folinic acid for the treatment of advanced or recurrent squamous cell carcinoma of the head and neck.
Comella P, Biglietto M, Della Vittoria Scarpati M, Stampino CG, Pandolfi A, Palmieri G, Carteni G, Catalano G, Comella G. Comella P, et al. Among authors: catalano g. Oncology. 1995 Jul-Aug;52(4):326-30. doi: 10.1159/000227483. Oncology. 1995. PMID: 7777248
Concurrent irinotecan and 5-fluorouracil plus levo-folinic acid given every other week in the first-line management of advanced colorectal carcinoma: a phase I study of the Southern Italy Cooperative Oncology Group.
Comella P, Casaretti R, De Vita F, Avallone A, Orditura M, Petrillo A, Gravina A, Faranda A, Comis S, Comella G, Catalano G. Comella P, et al. Among authors: catalano g. Ann Oncol. 1999 Aug;10(8):915-21. doi: 10.1023/a:1008339010655. Ann Oncol. 1999. PMID: 10509152 Free article. Clinical Trial.
CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative Group.
Lorusso V, Palmieri G, Bianco AR, Abate G, Catalano G, De Vita F, Dammacco F, Lauta VM, Lucarelli G, Polimeno G, Mantovani G, D'Aprile M, Marzullo F, De Lena M. Lorusso V, et al. Among authors: catalano g. Int J Oncol. 2000 Jan;16(1):149-54. doi: 10.3892/ijo.16.1.149. Int J Oncol. 2000. PMID: 10601560 Clinical Trial.
Oxaliplatin and raltitrexed combined with leucovorin-modulated 5-fluorouracil i.v. bolus every two weeks: a dose finding study in advanced previously treated colorectal carcinoma. Southern Italy Cooperative Oncology Group.
Comella P, De Vita F, De Lucia L, Casaretti R, Avallone A, Orditura M, Rivellini F, Palmeri S, Catalano G, Comella G. Comella P, et al. Among authors: catalano g. Ann Oncol. 2000 Apr;11(4):461-8. doi: 10.1023/a:1008308609978. Ann Oncol. 2000. PMID: 10847467 Free article. Clinical Trial.
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study).
De Vita F, Giuliani F, Orditura M, Maiello E, Galizia G, Di Martino N, Montemurro F, Cartenì G, Manzione L, Romito S, Gebbia V, Ciardiello F, Catalano G, Colucci G; Gruppo Oncologico Italia Meridionale. De Vita F, et al. Among authors: catalano g. Ann Oncol. 2007 Aug;18(8):1354-8. doi: 10.1093/annonc/mdm128. Epub 2007 May 24. Ann Oncol. 2007. PMID: 17525087 Free article. Clinical Trial.
726 results